newspaper
civil-litigation
class-action
securities
government-litigation
federal-courts
In re Amgen Inc. Securities Litigation
23-cv-02138
S.D.N.Y.
Advertisement
description
Case Summary
In re Amgen Inc. Securities Litigation is a civil case, docket number 23-cv-02138. The case is currently in a summary phase. No specific details about the allegations or proceedings are available.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • Securities fraud
- • Class action
- • Corporate litigation
smart_toy
Juryvine case summary generated from primary court records.
How we verify our work.
fact_check
Docket Snapshot
account_balance
Court
S.D.N.Y.
Southern District of New York · 2nd Circuit · NY
tag
Docket
Not captured
Civil
timeline
Stage
Active litigation
Active
event
Filed
Date unavailable
Not in the available feed
new_releases
Latest Filing
1:23-cv-02138 In re Amgen Inc. Securities Litigation
Other · Apr 24, 2026
newspaper
Coverage
1 article
1 source tracked
groups
Participants
Parties not parsed yet
1 linked entity
gavel
Judge
Not assigned in feed
What the record shows
This case is tied to Southern District of New York, a federal district court in NY.
The newest docket activity we have is a other dated April 24, 2026.
Party extraction has not produced a reliable plaintiff/defendant graph yet, so no speculative names are shown.
Press monitoring has found 1 related article from 1 distinct source.
chronic
Updated 10 hours, 54 minutes ago
The Story So Far
In re Amgen Inc. Securities Litigation is an active civil matter in Southern District of New York under docket 23-cv-02138.
The case is currently organized around In re Amgen Inc. Securities Litigation, federal court.
The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.
On April 24, 2026, the docket recorded a other: A securities class action lawsuit was filed against Amgen Inc. in the United States District Court for the Northern District of California. The lawsuit alleges that Amgen made false or misleading statements about its business and financial performance.
This.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
smart_toy
Juryvine case narrative generated from the full docket timeline.
How we verify our work.
About This Court
Southern District of New York (S.D.N.Y.) is a federal district court in the 2nd Circuit, NY.
Advertisement
Case Timeline
1 event
info
Other
April 24, 2026
1:23-cv-02138 In re Amgen Inc. Securities Litigation
A securities class action lawsuit was filed against Amgen Inc. in the United States District Court for the Northern District of California. The lawsuit alleges that Amgen made false or misleading statements about its business and financial performance. This lawsuit is significant because it may impact Amgen's stock price and reputation.
Advertisement
newspaper
1 article
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
4 hours, 32 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.